• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安非他酮用于治疗神经性疼痛。

Bupropion for the treatment of neuropathic pain.

作者信息

Shah Tanmay H, Moradimehr Abdolali

机构信息

East Tennessee State University, Quillen College of Medicine, Johnson City, TN, USA.

出版信息

Am J Hosp Palliat Care. 2010 Aug;27(5):333-6. doi: 10.1177/1049909110361229. Epub 2010 Feb 24.

DOI:10.1177/1049909110361229
PMID:20185402
Abstract

Neuropathic pain is a common problem in clinical practice, affecting patients physically, emotionally, financially, and socially. Current treatment includes antidepressants, antiepileptics, and opioid analgesics. Bupropion is a specific inhibitor of neuronal noradrenaline reuptake and a weak inhibitor of dopamine reuptake, which shows some promise in the treatment of neuropathic pain.

摘要

神经性疼痛是临床实践中的常见问题,在身体、情感、经济和社交方面影响着患者。目前的治疗方法包括使用抗抑郁药、抗癫痫药和阿片类镇痛药。安非他酮是一种特异性的去甲肾上腺素再摄取抑制剂,也是一种较弱的多巴胺再摄取抑制剂,在神经性疼痛的治疗中显示出一定前景。

相似文献

1
Bupropion for the treatment of neuropathic pain.安非他酮用于治疗神经性疼痛。
Am J Hosp Palliat Care. 2010 Aug;27(5):333-6. doi: 10.1177/1049909110361229. Epub 2010 Feb 24.
2
Antidepressants in the treatment of neuropathic pain.抗抑郁药治疗神经性疼痛。
Basic Clin Pharmacol Toxicol. 2005 Jun;96(6):399-409. doi: 10.1111/j.1742-7843.2005.pto_96696601.x.
3
[The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review].[抗抑郁药治疗慢性非癌性疼痛的有效性——综述]
Psychiatr Pol. 2005 Jan-Feb;39(1):21-32.
4
[Selective noradrenaline-dopamine reuptake inhibition (SNDRI). More latitude for antidepressive therapy].[选择性去甲肾上腺素-多巴胺再摄取抑制(SNDRI)。抗抑郁治疗的更多空间]
MMW Fortschr Med. 2007 May 21;149 Suppl 2:88-9.
5
[Successful treatment of depression in a Parkinson disease patient with bupropion].[用安非他酮成功治疗一名帕金森病患者的抑郁症]
Ned Tijdschr Geneeskd. 2000 Nov 4;144(45):2157-9.
6
Bupropion in the management of apathy.安非他酮在淡漠管理中的应用
J Psychopharmacol. 2004 Mar;18(1):133-5. doi: 10.1177/0269881104043284.
7
Treatment of panic disorder with bupropion in a patient with Parkinson's disease.用安非他酮治疗帕金森病患者的惊恐障碍。
J Clin Pharm Ther. 2008 Oct;33(5):575-7. doi: 10.1111/j.1365-2710.2008.00952.x.
8
[Use of cannabinoids in palliative medicine].[大麻素类药物在姑息治疗中的应用]
Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):822-5.
9
Helping patients to stop smoking.帮助患者戒烟。
Practitioner. 2002 Feb;246(1631):74, 79-80.
10
Efficacy of bupropion in the treatment of pemoline dependence.
Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):277-8.

引用本文的文献

1
Effectiveness of Extended-Release Bupropion and Duloxetine on Pelvic Pain and Sexual Function among Patients with Chronic Prostatitis/Chronic Pelvic Pain.缓释安非他酮和度洛西汀对慢性前列腺炎/慢性盆腔疼痛患者盆腔疼痛和性功能的疗效
Adv Biomed Res. 2024 Oct 28;13:98. doi: 10.4103/abr.abr_202_23. eCollection 2024.
2
Efficacy of antidepressants in the treatment of chronic nonspecific low back pain: a systematic review and meta-analysis.抗抑郁药治疗慢性非特异性下腰痛的疗效:系统评价和荟萃分析。
Pain Manag. 2024;14(8):437-451. doi: 10.1080/17581869.2024.2408215. Epub 2024 Oct 8.
3
Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV.
HIV 感染者中合并慢性疼痛和吸烟的患病率及其影响。
AIDS Care. 2021 Dec;33(12):1534-1542. doi: 10.1080/09540121.2021.1883511. Epub 2021 Feb 17.
4
Beyond Amitriptyline: A Pediatric and Adolescent Oriented Narrative Review of the Analgesic Properties of Psychotropic Medications for the Treatment of Complex Pain and Headache Disorders.除阿米替林外:一篇以儿童和青少年为导向的关于精神药物治疗复杂性疼痛和头痛疾病镇痛特性的叙述性综述
Children (Basel). 2020 Dec 2;7(12):268. doi: 10.3390/children7120268.
5
Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.反复使用单胺转运体抑制剂抗抑郁药对大鼠颅内自我刺激相关疼痛抑郁的影响。
Psychopharmacology (Berl). 2020 Jul;237(7):2201-2212. doi: 10.1007/s00213-020-05530-y. Epub 2020 May 8.
6
Novel approaches and current challenges with targeting the endocannabinoid system.靶向内源性大麻素系统的新方法和当前挑战。
Expert Opin Drug Discov. 2020 Aug;15(8):917-930. doi: 10.1080/17460441.2020.1752178. Epub 2020 Apr 27.
7
Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain.慢性脊髓损伤相关疼痛的非阿片类药物治疗。
J Spinal Cord Med. 2022 Mar;45(2):163-172. doi: 10.1080/10790268.2020.1730109. Epub 2020 Mar 17.
8
Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.脊髓损伤后中脑导水管周围灰质中多巴胺D1受体丧失及D1/5受体介导的细胞外信号调节激酶磷酸化减弱。
Neuroscience. 2017 Feb 20;343:94-105. doi: 10.1016/j.neuroscience.2016.11.040. Epub 2016 Dec 5.
9
Analgesic and anti-inflammatory activities of bupropion in animal models.安非他酮在动物模型中的镇痛和抗炎活性。
Res Pharm Sci. 2014 Jul-Aug;9(4):251-7.
10
The Effect of Acute Intra Locus Coeruleus (LC) Microinfusion of Bupropion on Formalin-Induced Pain Behavior in Rat.急性脑桥蓝斑核内微量注射安非他酮对大鼠福尔马林诱导的疼痛行为的影响。
Basic Clin Neurosci. 2014 Winter;5(1):31-41.